Literature DB >> 17664607

SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems.

Vanessa Panettieri1, Berit Wennberg, Giovanna Gagliardi, Maria Amor Duch, Mercè Ginjaume, Ingmar Lax.   

Abstract

The purpose of this work was to simulate with the Monte Carlo (MC) code PENELOPE the dose distribution in lung tumours including breathing motion in stereotactic body radiation therapy (SBRT). Two phantoms were modelled to simulate a pentagonal cross section with chestwall (unit density), lung (density 0.3 g cm(-3)) and two spherical tumours (unit density) of diameters respectively of 2 cm and 5 cm. The phase-space files (PSF) of four different SBRT field sizes of 6 MV from a Varian accelerator were calculated and used as beam sources to obtain both dose profiles and dose-volume histograms (DVHs) in different volumes of interest. Dose distributions were simulated for five beams impinging on the phantom. The simulations were conducted both for the static case and including the influence of respiratory motion. To reproduce the effect of breathing motion different simulations were performed keeping the beam fixed and displacing the phantom geometry in chosen positions in the cranial and caudal and left-right directions. The final result was obtained by combining the different position with two motion patterns. The MC results were compared with those obtained with three commercial treatment planning systems (TPSs), two based on the pencil beam (PB) algorithm, the TMS-HELAX (Nucletron, Sweden) and Eclipse (Varian Medical System, Palo Alto, CA), and one based on the collapsed cone algorithm (CC), Pinnacle(3) (Philips). Some calculations were also carried out with the analytical anisotropic algorithm (AAA) in the Eclipse system. All calculations with the TPSs were performed without simulated breathing motion, according to clinical practice. In order to compare all the TPSs and MC an absolute dose calibration in Gy/MU was performed. The analysis shows that the dose (Gy/MU) in the central part of the gross tumour volume (GTV) is calculated for both tumour sizes with an accuracy of 2-3% with PB and CC algorithms, compared to MC. At the periphery of the GTV the TPSs overestimate the dose up to 10%, while in the lung tissue close to the GTV PB algorithms overestimate the dose and the CC underestimates it. When clinically relevant breathing motions are included in the MC simulations, the static calculations with the TPSs still give a relatively accurate estimate of the dose in the GTV. On the other hand, the dose at the periphery of the GTV is overestimated, compared to the static case.

Entities:  

Mesh:

Year:  2007        PMID: 17664607     DOI: 10.1088/0031-9155/52/14/016

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  15 in total

Review 1.  Impact of dose calculation algorithm on radiation therapy.

Authors:  Wen-Zhou Chen; Ying Xiao; Jun Li
Journal:  World J Radiol       Date:  2014-11-28

2.  Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy.

Authors:  Jun Li; James Galvin; Amy Harrison; Robert Timmerman; Yan Yu; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-24       Impact factor: 7.038

3.  Algorithms used in heterogeneous dose calculations show systematic differences as measured with the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing.

Authors:  Stephen F Kry; Paola Alvarez; Andrea Molineu; Carrie Amador; James Galvin; David S Followill
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-01-01       Impact factor: 7.038

Review 4.  Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

Authors:  Tejan P Diwanji; Pranshu Mohindra; Melissa Vyfhuis; James W Snider; Chaitanya Kalavagunta; Sina Mossahebi; Jen Yu; Steven Feigenberg; Shahed N Badiyan
Journal:  Transl Lung Cancer Res       Date:  2017-04

5.  Effect of breathing motion in radiotherapy of breast cancer: 4D dose calculation and motion tracking via EPID.

Authors:  Anne Richter; Reinhard Sweeney; Kurt Baier; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

6.  Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.

Authors:  Ying Xiao; Lech Papiez; Rebecca Paulus; Robert Timmerman; William L Straube; Walter R Bosch; Jeff Michalski; James M Galvin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

7.  A dosimetric phantom study of dose accuracy and build-up effects using IMRT and RapidArc in stereotactic irradiation of lung tumours.

Authors:  Jan Seppala; Sami Suilamo; Jarmo Kulmala; Pekka Mali; Heikki Minn
Journal:  Radiat Oncol       Date:  2012-05-31       Impact factor: 3.481

8.  Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms.

Authors:  Wataru Takahashi; Hideomi Yamashita; Naoya Saotome; Yoshio Iwai; Akira Sakumi; Akihiro Haga; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2012-02-09       Impact factor: 3.481

9.  Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors.

Authors:  Masaru Narabayashi; Takashi Mizowaki; Yukinori Matsuo; Mitsuhiro Nakamura; Kenji Takayama; Yoshiki Norihisa; Katsuyuki Sakanaka; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2012-07-13       Impact factor: 2.724

10.  Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose.

Authors:  Danny Schuring; Coen W Hurkmans
Journal:  Radiat Oncol       Date:  2008-07-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.